Content
@
https://warpcast.com/~/channel/desci
0 reply
0 recast
0 reaction
peth.eth
@peth
Did you know scientists currently spend ~80% of time applying for funding instead of doing actual scientific work? Biggest bottleneck is in the early stages, in the range of $100 to $500k, which is referred to as the "valley of death" in academia. In the profit-maxi pharma industry, drugs that cannot be "properly" monetized, often wont even get developed at all. Ones that do, are likely to be overpriced.
2 replies
0 recast
2 reactions
peth.eth
@peth
😡 Extreme examples For example, price of Insulin increased x12 since 1996 & 2019. Or worse, a case when price of an IP protected drug Daraprim was increased >50x from $13.50 to $750 PER PILL. A somewhat happy ending where the owner was sued for blocking competition, was fined $64.6m, served time in prison and was banned from the pharma industry for life.
1 reply
0 recast
0 reaction
peth.eth
@peth
🤑 Patient-funded medicine Besides unlocking research funding, having patients as IP owners should lead to better pricing, as patients are not profit-driven and are more likely to be compassionate with fellow suferers. If only there was a way for patients to pool capital and co-own intellectual property... Well, now there is! There isn‘t a better capital formation mechanism than crypto, and there isn‘t a better way for collective ownership of intellectual property, than, again, crypto.
1 reply
0 recast
0 reaction